About us:
Abata is developing regulatory T cells (Tregs) therapies for autoimmunity to transform lives with cures for Multiple Sclerosis and Type 1 Diabetes. By arming Tregs with T cell receptors that provide tissue-specific activation at the site of disease, Tregs will restore homeostasis in the tissue enabling a robust, durable response, while avoiding systemic immune suppression.
Our work is fundamentally audacious which is why we hire the best, brightest, and most importantly…kind people. Being kind is not just a personality trait we look for, it’s a core value, embedded in the way we work and how we shape your experience at Abata Therapeutics. Our culture of learning and growth enables everyone to do their best work and contribute to fulfilling our mission.
Abata Therapeutics is currently seeking a highly motivated, self-driven, and creative individual with a deep expertise in immunology, cell therapy and gene engineering and is looking to join an outstanding research team dedicated to translating the biology of regulatory T cells into transformational medicines for patients. This individual will enjoy working in a pioneering, fast-paced and collaborative start-up environment with the opportunity to direct and oversee Early discovery, focused at the intersection of immunology, cell engineering, and cell manufacturing. This individual will join a culture of intellectual rigor, scientific curiosity, and collegiality, cross functionally contributing to research across the organization.
We view the candidate as an important team member whose contributions will be critical to our success in developing new therapeutics to improve the lives of patients.
We are an equal opportunity employer offering a competitive salary and benefits package. All applicants should be legally entitled to work for any employer in the US.
Note to Employment Agencies: Please do not forward any agency resumes. The company will not be responsible for any fees related to resumes that are unsolicited.
This is an on-site position based in the Watertown, MA office and the employee will be required to work in the office on a regular basis.
Abata Therapeutics will require compliance with our COVID- 19 vaccination policy. Please Review our conditions of employment.
Conditions of employment:
All current Abata employees have received the first two rounds of vaccinations against COVID-19. Vaccination status must be confirmed prior to any new hires joining the team. Up to date vaccination is strongly encouraged for every employee who intends to work onsite at our office and lab facility. Should an employee choose not to receive the vaccine, we will seek to understand the facts of their individual circumstance and determine if an appropriate work arrangement can be achieved.